{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:40Z","timestamp":1793053540206,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute of Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DK132121"],"award-info":[{"award-number":["R03DK132121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03AG71934"],"award-info":[{"award-number":["R03AG71934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Frailty, characterized by multi-system decline, increases vulnerability to adverse health outcomes and can be measured using Frailty Index (FI). We aimed to assess the prevalence of frailty in patients with adrenal disorders (based on hormonal sub-type) and examine association between FI and performance-based measures of physical function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Multi-centre, cross-sectional study (March 2019-August 2022).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adult patients with adrenal disorders (non-functioning adrenal adenomas [NFA], mild autonomous cortisol secretion [MACS], Cushing syndrome [CS], primary aldosteronism [PA]) and referent subjects without adrenal disorders completed a questionnaire encompassing 47 health variables (comorbidities, symptoms, daily living activities). FI was calculated as the average score of all variables and frailty defined as FI \u2265 0.25. Physical function was assessed with hand grip, timed up-and-go test, chair rising test, 6-minute walk test, and gait speed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared to referent subjects (n = 89), patients with adrenal disorders (n = 520) showed increased age, sex, and body mass index-adjusted prevalence of frailty (CS [odds ratio\u2014OR 19.2, 95% confidence interval\u2014CI 6.7-70], MACS [OR 12.5, 95% CI 4.8-42.9], PA [OR 8.4, 95% CI 2.9-30.4], NFA [OR 4.5, 95% CI 1.7-15.9]). Prevalence of frailty was similar to referent subjects when post-dexamethasone cortisol was &amp;lt;28\u2005nmol\/L and was higher when post-dexamethasone cortisol was 28-50\u2005nmol\/L (OR 4.6, 95% CI 1.7-16.5). FI correlated with all measures of physical function (P &amp;lt; .001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Whilst frailty prevalence was highest in patients with adrenocortical hormone excess, even patients with NFA demonstrated an increased prevalence compared to the referent population. Future longitudinal studies are needed to evaluate the impact of various management strategies on frailty.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvad113","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T22:51:56Z","timestamp":1692226316000},"page":"318-326","source":"Crossref","is-referenced-by-count":38,"title":["High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-1968","authenticated-orcid":false,"given":"Prerna","family":"Dogra","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"\u0160ambula","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, General Hospital Koprivnica , Zeljka Selingera 1, 48000, Koprivnica , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Saini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Thangamuthu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1693-3553","authenticated-orcid":false,"given":"Shobana","family":"Athimulam","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System , Detroit, MI 48202 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae A","family":"Delivanis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra A","family":"Baikousi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital , 45 Ipsilantou Street, Athens 106 76 , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Nathani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Department of Interna Medicine, UT Southwestern Medical Center , Dallas, TX 75390 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin , Milwaukee, WI 53210 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-8778","authenticated-orcid":false,"given":"Natalia","family":"Genere","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine , St. Louis, MO 63130 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Salman","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI 48109 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI 48109 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw , Poland Banacha 1a, 02-097, Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul G","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitabh","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Interna Medicine, UT Southwestern Medical Center , Dallas, TX 75390 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan K","family":"LeBrasseur","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine , Rochester, MN 55905 , United States"},{"name":"Robert and Arlene Kogod Center on Aging, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Zagreb , Kispaticeva 12, 10000 Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"4","key":"2023091408595864500_lvad113-B1","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1210\/clinem\/dgz284","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023091408595864500_lvad113-B2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023091408595864500_lvad113-B3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2023091408595864500_lvad113-B4","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023091408595864500_lvad113-B5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/ijerph16101872","article-title":"Malignancy risk and hormonal activity of adrenal incidentalomas in a large cohort of patients from a single tertiary reference center","volume":"16","author":"Cyranska-Chyrek","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"2023091408595864500_lvad113-B6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"2023091408595864500_lvad113-B7","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1210\/clinem\/dgab468","article-title":"Cardiometabolic outcomes and mortality in patients with adrenal adenomas in a population-based setting","volume":"106","author":"Zhang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023091408595864500_lvad113-B8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023091408595864500_lvad113-B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"9","key":"2023091408595864500_lvad113-B10","doi-asserted-by":"crossref","first-page":"e3307","DOI":"10.1210\/clinem\/dgaa410","article-title":"Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023091408595864500_lvad113-B11","doi-asserted-by":"crossref","first-page":"e2770","DOI":"10.1210\/clinem\/dgaa270","article-title":"Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: a long-term study","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091408595864500_lvad113-B12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-21-0458","article-title":"Abnormal body composition in patients with adrenal adenomas","volume":"185","author":"Delivanis","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023091408595864500_lvad113-B13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-20-1396","article-title":"Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study","volume":"184","author":"Li","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023091408595864500_lvad113-B14","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jbmr.398","article-title":"Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study","volume":"26","author":"Morelli","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2023091408595864500_lvad113-B15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"issue":"12","key":"2023091408595864500_lvad113-B16","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091408595864500_lvad113-B17","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"THERAPY OF ENDOCRINE DISEASE: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's Syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2023091408595864500_lvad113-B18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/gerona\/62.7.731","article-title":"Frailty: an emerging research and clinical paradigm\u2014issues and controversies","volume":"62","author":"Bergman","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2023091408595864500_lvad113-B19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ageing\/afx162","article-title":"Frailty index as a predictor of mortality: a systematic review and meta-analysis","volume":"47","author":"Kojima","year":"2018","journal-title":"Age Ageing"},{"issue":"1","key":"2023091408595864500_lvad113-B20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"issue":"1","key":"2023091408595864500_lvad113-B21","first-page":"e51","article-title":"Screening for frailty in primary care: accuracy of gait speed and hand-grip strength","volume":"63","author":"Lee","year":"2017","journal-title":"Can Fam Physician"},{"issue":"2","key":"2023091408595864500_lvad113-B22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02701367.1999.10608028","article-title":"A 30-s chair-stand test as a measure of lower body strength in community-residing older adults","volume":"70","author":"Jones","year":"1999","journal-title":"Res Q Exerc Sport"},{"issue":"5","key":"2023091408595864500_lvad113-B23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's Syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023091408595864500_lvad113-B24","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023091408595864500_lvad113-B25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jama.281.6.558","article-title":"Midlife hand grip strength as a predictor of old age disability","volume":"281","author":"Rantanen","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"2023091408595864500_lvad113-B26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2023091408595864500_lvad113-B27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/09593985.2011.601804","article-title":"Investigation into the reliability and validity of the measurement of elderly people's Clinical walking speed: a systematic review","volume":"28","author":"Rydwik","year":"2012","journal-title":"Physiother Theory Pract"},{"issue":"5","key":"2023091408595864500_lvad113-B28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1751-7133.2010.00151.x","article-title":"The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure","volume":"16","author":"Boxer","year":"2010","journal-title":"Congest Heart Fail"},{"issue":"8","key":"2023091408595864500_lvad113-B29","doi-asserted-by":"crossref","first-page":"E487","DOI":"10.1503\/cmaj.101271","article-title":"Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian national population health survey","volume":"183","author":"Rockwood","year":"2011","journal-title":"CMAJ"},{"key":"2023091408595864500_lvad113-B30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"2023091408595864500_lvad113-B31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cen.12823","article-title":"Moderately impaired renal function increases morning cortisol and cortisol levels at dexamethasone suppression test in patients with incidentally detected adrenal adenomas","volume":"83","author":"Olsen","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023091408595864500_lvad113-B32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cen.14811","article-title":"Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study","volume":"98","author":"Araujo-Castro","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023091408595864500_lvad113-B33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cen.13822","article-title":"Nonfunctioning adrenal incidentaloma: a novel predictive factor for metabolic syndrome","volume":"89","author":"Ribeiro Cavalari","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2023091408595864500_lvad113-B34","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad113\/51141934\/lvad113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/3\/318\/51550350\/lvad113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/3\/318\/51550350\/lvad113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:29:08Z","timestamp":1694705348000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/3\/318\/7244657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad113","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,17]]}}}